Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Prediabetes may be a risk factor for hair loss.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young adults with hair loss face higher risk of stiff arteries.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that more research is needed to fully understand the causes of PCOS.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Women with AGA have higher lipid levels, increasing heart disease risk.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.